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Abstract
Preterm birth (PTB) represents the leading cause of neonatalBackground: 
death. Large-scale genetic studies are necessary to determine genetic
influences on PTB risk, but prospective cohort studies are expensive and
time-consuming. We investigated the feasibility of retrospective recruitment
of post-partum women for efficient collection of genetic samples, with
self-collected saliva for DNA extraction from themselves and their babies,
alongside self-recollection of pregnancy and birth details to phenotype
PTB.
708 women who had participated in the OPPTIMUM trial (aMethods: 
randomised trial of progesterone pessaries to prevent PTB
[ISRCTN14568373]) and consented to further contact were invited to
provide self-collected saliva from themselves and their babies. DNA was
extracted from Oragene OG-500 (adults) and OG-575 (babies) saliva kits
and the yield measured by Qubit. Samples were analysed using a panel of
Taqman single nucleotide polymorphism (SNP) assays. A questionnaire
designed to meet the minimum data set required for phenotyping PTB was
included. Questionnaire responses were transcribed and analysed for
concordance with prospective trial data using Cohen’s kappa ( ).k
Recruitment rate was 162/708 (23%) for self-collected salivaResults: 
samples and 157/708 (22%) for questionnaire responses. 161 samples
from the mother provided DNA with median yield 59.0µg (0.4-148.9µg). 156
samples were successfully genotyped (96.9%). 136 baby samples had a
median yield 11.5µg (0.1-102.7µg); two samples failed DNA extraction. 131
baby samples (96.3%) were successfully genotyped. Concordance
between self-recalled birth details and prospective birth details was
excellent ( >0.75) in 4 out of 10 key fields for phenotyping PTB (mode ofk
delivery, labour onset, ethnicity and maternal age at birth).
This feasibility study demonstrates that self-collected DNAConclusion: 
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 This feasibility study demonstrates that self-collected DNAConclusion: 
samples from mothers and babies were sufficient for genetic analysis but
yields were variable. Self-recollection of pregnancy and birth details was
inadequate for accurately phenotyping PTB, highlighting the need for
alternative strategies for investigating genetic links with PTB.
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            Amendments from Version 1
The authors have taken into consideration the comments of the 
reviewers. Concordance between self-recalled birth details and 
prospective trial details has been calculated using Cohen’s kappa 
and correlation has been measured using Spearman’s rho: these 
results are displayed in the revised Table 3. We have used Venn 
diagrams (Figure 2 and Figure 3) as suggested by the reviewer to 
to show the overlapping of DNA samples between mothers and 
children and the overlapping between questionnaires and DNA 
samples, and we have confirmed Mendelian consistency between 
mother and child samples.
Any further responses from the reviewers can be found at the 
end of the article
REVISED
Introduction
Preterm birth is the leading cause of neonatal morbidity and 
mortality, resulting in an estimated economic burden to the 
public sector in England and Wales in excess of £2.9 billion 
over 18 years1. Spontaneous preterm birth (PTB) refers to birth 
less than 37 weeks gestation after the spontaneous onset of 
contractions2. In England in 2011/2012 27,509 babies were 
spontaneous PTBs, of which 11,480 were less than 32 weeks 
gestation3. Although our knowledge surrounding PTB and thus 
our ability to treat and prevent it has been increasing over time, 
95% of preterm births are intractable to current therapies4. 
Thus, further research into the pathogenesis of PTB is required 
to decrease this public health problem.
Research has shown that genetic factors contribute to sponta-
neous PTB. The strongest risk factor for PTB is a history of 
PTB2,5, with a recurrence rate after one spontaneous PTB of 
15%, which further increases the earlier the gestation, suggest-
ing a maternal genetic component to the risk. Another sugges-
tion of genetic association is the significant ethnic differences in 
incidence of PTB, with higher rates in women classified as 
black, African-American and Afro-Caribbean compared with 
white women, even when environmental confounding factors 
are taken into consideration2. A familial predisposition has 
also been shown, with women who were born preterm being 
more likely to have preterm babies themselves6, as well as 
women being more likely to have PTB if their sisters have had 
PTB7,8.
Recent advances in genetic and bioinformatic technologies 
now provide the potential to understand the complex interac-
tion of genetic and environmental factors. However, studies of 
genetic associations with pregnancy complications are depend-
ent on very large numbers of good quality DNA samples from 
well-phenotyped cases, preferably with samples from mother 
and baby pairs. Studies of genetic associations with conditions 
such as breast cancer and diabetes have successfully used postal 
recruitment, with participants donating DNA through provision 
of saliva samples, which can be returned by post9. This method 
could be an efficient way of sample collection from women 
who have had a PTB and their babies. However, it is crucial to 
know whether high quality phenotypic information can be 
provided alongside this approach. An international collaboration 
of researchers interested in genetic epidemiology studies of 
pregnancy has highlighted prerequisite phenotypic information 
essential for performing genetic association studies of preterm 
birth10. The group highlights the important differences between 
spontaneous PTB (spontaneous onset of contractions), spon-
taneous PTB with preterm premature rupture of membranes 
(PPROM), and medically indicated PTB (medical indications 
being fetal compromise, such as small for gestational age, or 
maternal compromise, for example severe pre-eclampsia)10. 
The genetic associations and pathophysiology underlying these 
three conditions vary greatly10, hence the necessity for accu-
rate phenotyping in genetic studies in this field specifically. 
Furthermore, it has not yet been established if maternal recall 
would be of sufficient quality to support such research. It is 
also unknown whether postal recruitment and self-collection of 
samples from mothers, and maternal collection of samples from 
infants, would be acceptable to participants or yield sufficient 
quantity and quality of DNA.
There are three aims of this study, which was completed in 
collaboration with mother and baby pairs from women who 
took part in the OPPTIMUM trial11. Firstly, to pilot the 
method of postal recruitment and sample collection, return and 
processing. Secondly, to confirm that maternally collected 
saliva samples, particularly from infants, provide sufficient 
high quality DNA yield. Thirdly, to assess the agreement of 
self-recalled pregnancy and birth details in a questionnaire, 
including essential information for preterm birth genetic 
association studies, compared with prospectively collected 
OPPTIMUM trial data.
Methods
Participants
We included UK based participants from the OPPTIMUM trial, 
a double-blind, randomised, placebo-controlled trial investigating 
the effect of vaginal progesterone on pregnancy and infant 
outcomes in women at high risk of spontaneous PTB 
(https://doi.org/10.1186/ISRCTN14568373)11. OPPTIMUM recruited 
from 65 UK National Health Service (NHS) Hospitals 
and 1 Swedish hospital between February 2009 and April 2013. 
The inclusion criteria for the OPPTIMUM trial were: high risk 
for PTB, gestation established by scan at ≤ 16 weeks to ensure 
that estimated date of delivery is accurate, signed consent 
form and aged 16 years or older (no upper age limit). Exclu-
sion criteria for the OPPTIMUM trial were: known significant 
congenital structural or chromosomal fetal anomaly, known 
sensitivity, contraindication or intolerance to progesterone, 
suspected or proven rupture of the fetal membranes at the time 
of recruitment, multiple pregnancy, prescription or ingestion of 
medications known to interact with progesterone and women 
who were prescribed progesterone who took progesterone 
beyond 18 weeks gestation (See extended data: Appendix 212). 
For this study, we excluded women who: had withdrawn their 
consent from the OPPTIMUM trial, those of whom we had 
no contact details, those whose babies had died subsequent to 
the 2-year follow-up period, and those who were recruited in 
Sweden (Figure 1).
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Recruitment
Potential participants were sent a letter of invitation to the 
“OPPTIMUM genetics” study from 20th April 2015 to 23rd July 
2015 (see extended data12). Women who had a stillbirth, neona-
tal or infant death were sent an alternate letter of invitation (see 
extended data12). Women were asked to reply by email, phone, 
text or post to indicate their interest in participating. The study 
lasted for 12 months after the last recruitment pack was sent 
out.
Sample collection
Women who responded positively to the invitation letter were 
sent a recruitment pack (see extended data: Appendix 312). 
Women who had a live infant were invited to provide a saliva 
sample from themselves and their baby born whilst participat-
ing in the OPPTIMUM study; for those women who had experi-
enced infant loss, an alternative pack was sent with a collection 
kit for themselves only. The recruitment packs contained 
a recruitment letter, patient information leaflet, maternal 
consent form (2 copies), child assent form (if child over 
4 years old), instructions for saliva sample collection for 
mother and maternal saliva sample collection kit (Oragene 
OG-500, DNA Genotek), a clinical data questionnaire and a 
postal return kit (postage paid; see extended data12). Where 
appropriate, instructions for saliva sample collection for baby, 
and an infant saliva sample collection kit (Oragene OG-575, 
Figure 1. Study flow diagram of recruitment.
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DNA Genotek) was included. If the participant’s baby had died, 
they were invited to provide a saliva sample from themselves, 
and an alternative recruitment pack was sent (see extended data: 
Appendix 312). Women who had not returned the recruitment 
pack after 6–8 weeks were sent a single reminder letter.
Questionnaire design and application
The questionnaire was designed by the OPPTIMUM trial team 
to meet the minimum data required for a study of PTB13 and 
was piloted in 20 postpartum women. It included questions on 
gestation at birth, maternal age at birth, birth method, labour 
onset, membrane rupture, maternal smoking, non-prescription 
drug use and alcohol intake, as well as the number of previ-
ous pregnancies and maternal ethnic origin (see extended 
data: Appendix 112). Participants were asked to answer the 
questions in relation to their pregnancy during the OPPTIMUM 
trial.
Receipt, processing and storage of samples
The Edinburgh Clinical Research Facility Genetics Core received 
and processed the samples. Samples were identified by the 
OPPTIMUM trial number, with a suffix for mother and baby 
and labelled with details readable by barcode scanner.
DNA extraction and validation
DNA was extracted from Oragene OG-500 (adults) and OG-575 
(babies) saliva kits using Oragene prepIT (PT-L2P-5) extraction 
kit (supplied by DNA Genotek). DNA yield was measured by 
Qubit (ThermoFisher). Samples were genotyped on a panel 
of Taqman single nucleotide polymorphisms (SNPs) using 
the QuantStudio12K Flex and analysed using QuantStudio 
v1.2.2 software. Samples from mothers were genotyped using 
autosomal SNPs rs6427699, rs4751955, rs11083515, rs7588807, 
rs10938367 & rs10869955. Samples from babies were run on 
the same six autosomal SNPs and an additional three SNPs 
from the Y-chromosome to determine sex (rs2032598, rs768983 
& rs3913290). An aliquot of DNA was normalised in plates for 
future analysis. DNA samples were transferred for storage and 
used as part of the Edinburgh Reproductive Tissues Biobank 
(REC reference 09/S0704/3).
Data analysis
For this study, data was transcribed from the questionnaires 
and appropriate information was obtained from the trial 
database. Patient identifiable information was removed and 
trial data was correlated with the corresponding questionnaire 
through randomised OPPTIMUM trial numbers. In keeping 
with the Caldicott principles14, access to trial data was only 
granted to members of the research team, and stored on a 
password protected database on a secure server (University of 
Edinburgh). The concordance between self-recalled birth 
details and prospective trial birth details was then analysed for 
gestation at birth, maternal age at birth, mode of birth, onset 
of labour, smoking, non-prescription drug use, alcohol use 
and number of previous pregnancies. The concordance for 
PPROM was analysed in women who had a PTB. Concordance 
was measured using Cohen’s kappa coefficient. The kappa (k) 
statistic measures the extent of exact agreement, adjusting for 
chance agreement with values greater than 0.75 representing 
excellent concordance, values of 0.40 to 0.75 representing 
moderate concordance and values less than 0.40 representing 
poor concordance15. In addition, Spearman’s rho (r) correlation 
coefficient was calculated for each variable.
We pre-specified that a participation rate of ≥ 50% would be 
acceptable and k > 0.75 would be sufficient for phenotyping 
PTB. These values were chosen by the research team as previ-
ous studies of self-collected DNA samples have had participation 
rates above 50%16,17 and accurate recall using patient question-
naires would be necessary for any future large scale studies 
using this design.
Statistical analysis
All data was analysed using IBM Statistical Package for the 
Social Sciences (SPSS) Version 22. Normally distributed data 
was analysed using a t-test. The Fishers exact test was used 
for proportional data. A p-value of <0.05 was considered 
significant.
Ethical opinion
This study was awarded a favourable ethical opinion by the 
regional ethics committee (REC reference 14/SS/0086).
Results
Recruitment rate and participant demographics
In total, 708 women were contacted. From these, 157 
questionnaires were returned, a participation rate of 22%. 
Overall, 299 DNA sample kits were received (137 mother and 
baby paired samples, 24 mother only samples, 1 baby only 
sample) - a participation rate of 162/708 (23%) (see Figure 1 
and Figure 2). Seven participants returned a DNA sample kit 
without a questionnaire and 2 participants returned the ques-
tionnaire without a DNA sample. One participant was recruited 
twice to the OPPTIMUM trial and so returned a question-
naire for each pregnancy, a mother and baby paired sample from 
her first child and a baby only sample from her second child 
(See Figure 3). See underlying data for all data collected12.
The demographics of the questionnaire respondents are shown 
in Table 1. To determine if these 157 women were representa-
tive of the OPPTIMUM trial population the demographics 
of the participants in this pilot study were compared to that 
of the entire cohort of OPPTIMUM trial participants. This 
highlighted that the pilot study participants were significantly 
older, more educated, had a higher proportion of white par-
ticipants, and a lower proportion of black participants compared 
with the entire OPPTIMUM cohort (Table 1).
DNA extraction and quality assessment
DNA was extracted from 299 saliva samples. All 161 samples 
from the mother provided DNA with median yield 59.0µg 
(0.4-148.9µg). Two baby samples failed and provided no DNA. 
The remaining 136 baby samples had a median yield 11.5µg 
(0.1-102.7µg) (Table 2). Samples were genotyped using a 
panel of six autosomal Taqman SNPs and were deemed suit-
able for genomic analysis if they successfully genotyped on five 
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Figure 2. Venn diagram demonstrating DNA samples received: 
24 mother only  samples,  1 baby only  sample  and 137 mother 
and baby paired samples.
Figure 3. Venn diagram demonstrating the overlap of number of 
questionnaires received and number of DNA samples received: 
2  respondents  returned  the  questionnaire  without  DNA 
samples, 7 returned DNA samples without a questionnaire and 
155 returned both DNA samples and questionnaire.
or more SNPs. 156 of the 161 samples (96.9%) from the mother 
successfully genotyped (one sample failed on four SNPs, 
three samples failed on five SNPs and one sample failed on 
all six SNPs). 131 of the 136 baby samples (96.3%) success-
fully genotyped (three samples failed on five SNPs and two 
samples failed on all six SNPs) (Table 2). For those genotypes 
that were homozygous in the mother and the child we were able 
to demonstrate Mendelian consistency. Across the 6 autosomal 
SNPs there were 204 genotype calls we could compare. 
201 showed Mendelian consistency. 3 genotype calls were 
inconsistent.
The baby samples were additionally genotyped on three 
Y-chromosome SNPs. Samples that successfully called on five 
or six autosomal SNPs were checked for sex, with samples 
having a no-call on all three Y-chromosomes SNPs determined 
as female and samples having a call on all three Y-chromosome 
SNPs determined as male. Samples having a positive call 
on only one or two Y-chromosome SNPs were assigned 
to ‘unknown’, of which 5 of 131 samples were assigned. 
Additionally, 2 samples did not have matched trial data to verify 
sex. In total, 121 of 124 samples (97.6%) correctly identified 
the sex of the baby; 3 samples which were assumed female 
from genotyping were male (Table 2).
Concordance and correlation of self-recalled birth details 
and prospective trial birth details
Concordance of self-recalled birth details and prospective 
trial birth details for each variable are displayed in Table 3. 
Concordance using Cohen’s kappa was excellent (k > 0.75) in 
4 out of 10 key fields for phenotyping PTB (mode of delivery, 
labour onset, ethnicity and maternal age at birth). Concordance 
was moderate (0.4 < k < 0.75) for smoking status, gestation 
at birth and number of previous pregnancies, and poor (k < 0.4) 
for alcohol use and drug use. The concordance for PPROM 
was assessed in only 11 cases, where PPROM led to preterm 
birth. Only 6 participants out of the 11 cases recalled 
PPROM prior to having a preterm birth. It was not possible to 
calculate Cohen’s kappa for this group as the trial cohort had 
only one variable, but Spearman’s rho correlation coefficient 
was weak at 0.224.
Correlation measured using Spearman’s rho (r) was very strong 
(r = 0.8 - 1.0) in five fields for phenotyping PTB (mode of 
delivery, labour onset, ethnicity, maternal age at birth and ges-
tation at delivery). Spearman’s rho was strong (r = 0.60 – 0.79) 
for smoking status and number of previous pregnancies, weak 
(r = 0.20 – 0.39) for alcohol use and very weak (r = 0.00-0.19) 
for drug use.
Smoking status, non-prescription drug use, alcohol 
consumption
There was no statistical difference found between the number 
of smokers reported in prospective trial data and self-recalled 
data (p=0.838). The difference in non-prescription drug 
use between prospective trial data and self-recalled data 
was statistically significant (p=0.0001); 18/157 (11%) of women 
recorded as no drug use in prospective trial data classified 
themselves as having used non-prescription drugs during their 
pregnancy. A subset of these women (10/18, 56%) included 
the names of the drugs used; these included paracetamol, 
aspirin, folic acid, codeine and “indigestion medication”. The 
difference between alcohol consumption in prospective 
trial data and self-recalled data was statistically significant 
(p=0.0005); 23/148 (16%) women recorded as non-drinkers in 
prospective trial data self-recalled use of alcohol during their 
pregnancy.
Discussion
The primary aim of this study was to pilot postal donation 
of self-collected DNA samples from postpartum women and 
their babies. The recruitment rate of 23% was below our 
pre-specified response rate of ≥ 50% and compares poorly with 
other studies investigating self-collection of DNA which have had 
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Table 2. Results of DNA analysis and genotyping from mother and baby self-collected saliva 
samples.
Mother samples 
(n=161)
Baby samples 
(n=138)
Number of samples suitable for analysis 161 (100%) 136 (98.6%)
Median DNA yield in μg (range) 59.0 (0.4-148.9) 11.5 (0.1-102.7)
Number of samples successfully genotyped using 6 autosomes 156/161 (96.9%) 131/136 (96.3%)
Number of samples correctly identifying sex 121/124 (97.6%)
Table 1. Demographics of study participants.
Pilot study OPPTIMUM trial 
cohort
N n (%) or 
mean (SD) N
n (%) or mean 
(SD)
Age (years) 157 32.8 (5.5)* 1225 31.5 (5.7)
Smoking 157 14 (9%) 1220 63 (5%)
Alcohol 157 9 (6%) 1223 63 (5%)
Drug use 157 1 (0.6%) 1223 17 (1%)
Years in full-time education 147 14.4 (3.1)** 1122 13.5 (3.0)
Ethnic group
     White 157 139 (89%)** 1224 895 (73%)
     Black 157 8 (5%)** 1224 180 (15%)
     Asian 157 6 (4%) 1224 104 (8%)
     Mixed 157 3 (2%) 1224 28 (2%)
     Other 157 0 (0%) 1224 17 (1%)
Any previous pregnancy 154 147 (95%) 1224 1172 (96%)
History of preterm birth (any) 154 121 (79%) 1223 966 (79%)
Demographics of participants in the pilot study group (taken from OPPTIMUM trial data) 
versus the complete OPPTIMUM trial cohort. Each field was analysed for statistical 
differences between these two groups. SD = standard deviation. * = p<0.05, ** = p<0.001, 
*** = p<0.0001
participation rates greater than 50%16,17. Only one reminder 
was sent - it is possible that further reminders might have 
increased the participation rate. We recruited participants from 
a cohort of women who had previously taken part in the OPP-
TIMUM trial. Although this limited our study population, 
the main advantages were that consent had already been 
obtained and that high quality prospectively collected data on 
demographics and birth outcomes was available for validation.
The Preterm Birth Genome Project investigated multiple meth-
ods of DNA collection from mother and baby pairs (whole 
blood, blood spot, buccal, saliva) from four countries and found 
that samples were not affected by transportation methods and 
that salivary samples provided an adequate yield of DNA, 
superior to buccal swabs18. Similar studies of self-collected 
saliva samples report DNA yields of > 70%19,20. Our study 
shows that postal self-collected saliva samples from mothers and 
babies were of sufficient quality for genetic analysis but yields 
were variable.
We also aimed to determine the concordance between 
self-recalled birth details and prospective trial birth details with 
a view to determine if postal questionnaires are a valid method 
of phenotyping PTB. We demonstrate that concordance was 
above the pre-specified k > 0.75 in only four out of ten 
questions. It is very unlikely that the prospectively collected 
OPPTIMUM trial data was erroneous. The study was carried 
out to rigorous clinical trial standards with a pre-defined data 
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dictionary and training of all research staff contributing to data 
collection. There was regular trial data monitoring from the 
sponsor ensuring data quality and consistency with checking of 
source data.
Labour onset and membrane rupture are important features 
which differentiate spontaneous PTB from PTB following 
PPROM and medically indicated PTB. This is crucial, as the 
underlying genetic basis for each phenotype is potentially differ-
ent. In this dataset, concordance for labour onset was excellent 
(k = 0.839). The correlation between self-recalled details and 
trial data for the occurrence of PPROM in women who had 
a PTB was weak suggesting that PPROM is not accurately 
recalled. However, we recognise that this is a very small subset 
of women and a larger number would be required to accurately 
assess this finding.
In contrast to the moderate level of concordance for smoking 
status, the concordance between prospective trial data and 
self-recalled data was poor with regards to non-prescription 
drug use and alcohol intake: a much higher level of alcohol con-
sumption was reported in self-recalled data than in prospective 
trial data. Interestingly, the discrepancies between the reporting 
of smoking, alcohol and non-prescription drug use are in both 
directions. This highlights differences in public perception and 
willingness to disclose such information whilst in a research 
trial or in an anonymised questionnaire. The inconsistencies 
in reporting of non-prescription drug use were mainly due to 
several women self-recalling use of ‘over the counter’ 
medications such as paracetamol. This is in contrast to the 
OPPTIMUM trial definition of non-prescription drug use 
which included: heroin, cocaine or abuse of prescribed drugs 
such as benzodiazepines. This finding is most likely due to a 
misinterpretation of the question and highlights the importance 
of accurate wording in similar questionnaire studies.
In conclusion, this feasibility study shows that women can 
successfully collect DNA from themselves and their babies, 
but overall yields were variable. Yield from babies was lower 
than mothers due to the lower amount of saliva collected 
with the Oragene OG-575. Taqman genotyping showed the 
samples were suitable for variant calling and checking sex. 
The low yields, particularly for the baby samples, would 
make some methods of genomic analysis challenging, such as 
exome sequencing, but with the development of low-input kits 
even these methods may be suitable. Consideration should be 
given to the genetic analysis to be performed when deciding 
on a collection method.
Table 3. Table displaying Cohen’s kappa coefficient as a measure of concordance and Spearman’s 
rho coefficient as a measure of correlation of prospective trial birth details with self-recalled 
pregnancy and birth details. A p-value of <0.01 is statistically significant.
N Missing 
self-recall 
data
Missing 
prospective 
trial data
Cohen’s 
kappa  
(p value)
Spearman’s 
rho 
(p value)
Mode of delivery 157 1 
(0.6%)
0.974 
(0.000)
0.956 
(0.000)
Labour onset 157 1 
(0.6%)
1 
(0.6%)
0.839 
(0.000)
0.822 
(0.000)
Ethnicity 157 1 
(0.6%)
0.812 
(0.000)
0.868 
(0.000)
Maternal age at birth 157 1 
(0.6%)
0.797 
(<0.001)
0.980 
(0.000)
Smoking status 157 0.749 
(0.000)
0.751 
(0.000)
Gestation at birth 157 1 
(0.6%)
3 
(2%)
0.742 
(0.000)
0.908 
(0.000)
Number of previous pregnancies 157 0.536 
(0.000)
0.686 
(0.000)
Alcohol use 157 1 
(0.6%)
0.297 
(0.000)
0.368 
(0.000)
Drug use 157 1 
(0.6%)
1 
(0.6%)
0.012 
(0.716)
-0.029 
(0.718)
Preterm premature rupture of 
membranes
11 Not 
possible
0.224 
(0.121)
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We found postal post-partum participation rates are low and 
there were significant discrepancies between self-recall of 
pregnancy and birth details and prospective birth details as 
recorded in the OPPTIMUM trial dataset. We conclude that 
information gathered from postal questionnaires is insufficient 
to accurately phenotype PTB and clinical data collection from 
medical records needs to be an integral part of any future 
study design into the genetics of preterm birth.
Data availability
Underlying data
Figshare: Postal recruitment for genetic studies of preterm birth: 
A feasibility study. https://doi.org/10.6084/m9.figshare.788708312
This project contains the following underlying data:
-     Figshare1. DNA data.csv (Dataset showing total DNA 
yield for all self-collected samples)
-     Figshare2. OPPTIMUM trial data.csv (Prospective trial 
data)
-     Figshare3. Questionnaire data.csv (Data from participant 
questionnaires)
-     Figshare4. Comparison results of y markers_281019_
BABY.csv (Results of determining sex of baby from 
saliva samples)
-     Figshare5. Taqman Genotyping Report_291019.pdf 
(Report detailing results of Taqman genotyping)
-     Genotyping results for 6 x SNPs using mother and 
baby samples (individual files for Taqman genotyping 
results for mother and baby for each SNP: rs6427699, 
rs4751955, rs11083515, rs7588807, rs10938367 & 
rs10869955)
Extended data
Figshare: Postal recruitment for genetic studies of preterm birth: 
A feasibility study. https://doi.org/10.6084/m9.figshare.788708312
This project contains the following extended data:
-     Appendix 1. Participant questionnaire (example of 
participant questionnaire)
-     Appendix 2. OPPTIMUM trial inclusion and exclusion 
criteria (list of inclusion and exclusion criteria for 
recruitment to the OPPTIMUM trial)
-     Appendix 3. List of recruitment pack contents (list of 
recruitment pack contents for women who had a live birth, 
and for women who had a stillbirth, neonatal or infant 
death)
-     OPPTIMUM Genetics invitation letters (invitation let-
ters to participate in OPPTIMUM Genetics study, one for 
women who had a live birth, one for women who had a 
stillbirth, neonatal or infant death)
-     Recruitment pack letters (letters included in recruit-
ment pack, one for women who had a live birth, one for 
women who had a stillbirth, neonatal or infant death)
-     OPPTIMUM genetics patient information leaflets (patient 
information leaflets, one for women who had a live 
birth, one for women who had a stillbirth, neonatal or 
infant death)
-     OPPTIMUM genetics consent forms (participant consent 
form, one for women who had a live birth including con-
sent for her baby or child to participate, one for women 
who had a stillbirth, neonatal or infant death)
-     OPPTIMUM genetics child assent form (for children 
over 5 years of age to assent to participation in study)
-     Saliva sample collection instructions (instructions on 
how to collect saliva sample from participant and from 
baby or child using Oragene saliva kits)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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 Ge Zhang
Division of Human Genetics, The Center for Prevention of Preterm Birth, Perinatal Institute, Cincinnati
Children's Hospital Medical Center, Cincinnati, OH, USA
This pilot study evaluated the feasibility of retrospective collection of DNA samples and self-recalled
phenotype data for genetic studies of preterm birth. The study demonstrated the DNA samples were
sufficient for genetic analysis but the self-recalled phenotype data was inaccurate. The reviewer has
major concern with using concordance in evaluating the consistency of phenotype data.
Introduction: ref 11 demonstrated that successful genetic studies of gestational duration and
preterm birth require large sample sizes. It did not study the genetic or pathophysiological
differences among sPTB, PPROM and indicated PTB.
 
Methods (Data analysis): The calculation of concordance should be explicitly explained.
 
Methods (Data analysis): In addition to concordance, the authors should check correlations
(especially for quantitative variables and binary variables) between the self-recalled data and data
collected from the clinical trial.
 
Results (first paragraph): The authors may provide Venn diagrams to show the overlapping of DNA
samples between mothers and children [24 (137) 1] and overlapping between questionnaires and
DNA samples [2 (155 ) 7].
 
Results (second paragraph and Table 1): It should be clarified that the numbers [n(%)] were
calculated based on trial data even for the pilot study.
 
Results (DNA quality assessment): The author should present Mendelian consistency between
mothers and their child.
 
Results (Table 3): concordance of PPROM was calculated as 6/11 (55%), which might be incorrect
(please also see my comment 2).
 
Results (Please also see my comments 2 and 3): It seems to the reviewer that concordance is not
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 8.  Results (Please also see my comments 2 and 3): It seems to the reviewer that concordance is not
an adequate measure to evaluate the consistency between self-recalled data and the data
collected during the trial. For example, only 1 mother in the pilot study was recorded having
non-prescription drugs; but 18 recorded as no drug use recalled themselves as having used
non-prescription drugs. This information is totally inconsistent and misleading but still the
concordance is 88% = (155-(18+1))/155. The same is true for alcohol consumption. As suggested
by my comment 3, the authors should check correlations or present Venn diagrams for every
categorical variable to show the complete picture of relationships between the two data sets.
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Is the study design appropriate and is the work technically sound?
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Are sufficient details of methods and analysis provided to allow replication by others?
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If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Statistical genetics
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons
outlined above.
Author Response 23 Jun 2020
, NHS Lothian, UKOonagh Keag
 1. Introduction: ref 11 demonstrated that successful genetic studies of gestational
duration and preterm birth require large sample sizes. It did not study the genetic or
pathophysiological differences among sPTB, PPROM and indicated PTB.
Thank you for your comment. Where ref 11 was cited, it should have been ref 10 – the Pennell
group highlights the important differences between spontaneous PTB, spontaneous PTB with
PPROM and medically indicated PTB. This group stresses the necessity for accurate phenotyping.
This has been corrected in the revised version.
 
2. Methods (Data analysis): The calculation of concordance should be explicitly
explained. 
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 explained. 
Concordance was analysed by directly comparing the trial data to the participant questionnaire
responses and determining the percentage of responses which were the same. SPSS was used to
calculate the 95% confidence intervals. The authors are aware of the use of Cohen’s kappa
coefficient in measuring concordance and have calculated this for each variable. These results are
similar to the direct observation of concordance except for in drug use, alcohol use and for
PPROM. The kappa statistic measures the extent of exact agreement, adjusting for chance
agreement with values greater than 0.75 representing excellent concordance; values of 0.40 to
0.75 representing moderate concordance; and values less than 0.40 representing poor
concordance. (Ref: Landis JR, Koch GG: The measurement of observer agreement for categorical
data. Biometrics. 1977, 33 (1): 159-174. 10.2307/2529310.) The authors agree that the kappa
statistic is more reflective of the agreement of the trial and questionnaire data and so the direct
comparison method has been removed in version 2 and the table updated (see Table 3).
 
3. Methods (Data analysis): In addition to concordance, the authors should check
correlations (especially for quantitative variables and binary variables) between the
self-recalled data and data collected from the clinical trial. 
Spearman correlation coefficients have been calculated for each variable and are displayed in
Table 3 of the revised version.
 
4. Results (first paragraph): The authors may provide Venn diagrams to show the
overlapping of DNA samples between mothers and children [24 (137) 1] and overlapping
between questionnaires and DNA samples [2 (155 ) 7]. 
Thank you for your suggestion of Venn diagrams to describe our results. We have added these to
the revised version as Figures 2 and 3.
 
 5. Results (second paragraph and Table 1): It should be clarified that the numbers [n(%)]
were calculated based on trial data even for the pilot study. 
We can clarify that the demographics of the questionnaire respondents described in Table 1 are
based on the trial data.
 
6. The author should present Mendelian consistency between mothers and their child. 
We can only do this by looking at those genotypes that are homozygous in the mother and the
child, as we have no paternal information. On this basis, across the 6 autosomal SNPs there were
204 genotype calls we could compare. 201 showed Mendelian consistency. 3 genotype calls were
inconsistent (presumably these were then 3 mic-calls). Added to the sex-chromosome data where
all samples were correctly allocated gender we think we have shown accuracy of sample collection
and genotyping.
 
7. Results (Table 3): concordance of PPROM was calculated as 6/11 (55%), which might
be incorrect (please also see my comment 2). 
The concordance for PPROM was assessed in only 11 cases, where PPROM led to preterm birth.
6 participants out of the 11 cases recalled PPROM prior to having a preterm birth, 6/11 = 55%. It
was not possible to calculate Cohen’s kappa for this group as the trial cohort had only one variable.
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 was not possible to calculate Cohen’s kappa for this group as the trial cohort had only one variable.
 
8. (Please also see my comments 2 and 3): It seems to the reviewer that concordance is
not an adequate measure to evaluate the consistency between self-recalled data and the
data collected during the trial. For example, only 1 mother in the pilot study was recorded
having non-prescription drugs; but 18 recorded as no drug use recalled themselves as
having used non-prescription drugs. This information is totally inconsistent and
misleading but still the concordance is 88% = (155-(18+1))/155. The same is true for
alcohol consumption. As suggested by my comment 3, the authors should check
correlations or present Venn diagrams for every categorical variable to show the
complete picture of relationships between the two data sets.
Thank you for your comments. The authors agree that in the alcohol use and non-prescription drug
use groups there are significant discrepancies which aren’t so apparent when concordance is
presented. This does become apparent when Cohen’s kappa is calculated; its value is low in both
groups, as seen in Table 3 of the revised version. This is the same when correlation is measured in
these groups using Spearman’s coefficient. The authors attempt to address these inconsistencies
in the discussion, highlighting the potential misunderstanding or misinterpretation of the drug use
question, evident from the free text answers including over the counter medications such as
paracetamol. 
 We have no competing interests to disclose.Competing Interests:
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 Kelly-Ann Eastwood
Centre for Public Health, Institute of Clinical Sciences, Block B, Royal Victoria Hospital, Queen’s
University Belfast, Belfast, UK
This is an interesting study investigating feasibility of self-collected postnatal maternal and neonatal saliva
for DNA extraction. The paper is well written and of interest to clinicians and researchers.
The authors have clearly discussed limitations of the study, including recruitment rate (23%) and poor
concordance between self-recalled birth details and prospective trial data.
I wonder if recruitment rate may have in fact been bolstered by previous participation in the OPTIMMUM
study. This could have implications in a real world clinical setting. Regarding collection of saliva samples;
median DNA yield demonstrated a large range for both mother and neonatal samples. Going forward,
how could integrity of sampling technique be assured?
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Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Maternal and Fetal medicine, preterm labour, multiple pregnancy
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
 19 February 2020Reviewer Report
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, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution License
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 Tessa Homfray
 South West Thames Regional Genetics ServiceSouth West Thames Regional Genetics Service, St
George's University Hospitals NHS Foundation Trust, London, UK
 Harris Birthright Unit, King's College Hospital, London, UK
I am uncertain exactly when these women were recruited. The OPPTIMUM study was 2013 and
therefore this was sometime later that this was attempted which would I suspect lead to the poorer
recall than if this had been attempted later.
 
The amount of baby saliva DNA would be too small to be of much use I suspect. 
 
I didn't see any evidence confirming maternity of the fetal samples which would indicate if they had
been collected correctly.
 
This is a proof of principle study which suggests this is not a good method of obtaining genetic
material. On this basis I think the article should be much shorter.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
1
2
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 Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Consultant Medical Genetics with Particular interest in fetal medicine.
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons
outlined above.
Author Response 23 Jun 2020
, NHS Lothian, UKOonagh Keag
1. I am uncertain exactly when these women were recruited. The OPPTIMUM study was
2013 and therefore this was sometime later that this was attempted which would I suspect
lead to the poorer recall than if this had been attempted later.
Thank you for your comment. Although the OPPTIMUM trial finished recruitment in 2013, the study
did not complete until July 2015 when we conducted the final childhood assessment at age 2. The
trial team were in regular contact with many of the women for more than 5 years, on childhood
birthdays and sending Christmas cards, newsletter and there was a facebook page with which
many women engaged. As described in the methods, participants for this feasibility study were
recruited in 2015, which would explain poorer recall in some areas. The reasons for using the
OPPTIMUM participants was that consent had already been obtained for future contact and we
had high quality prospectively collected data with which to compare questionnaire responses.
 
2. The amount of baby saliva DNA would be too small to be of much use I suspect.
 
Yes we have extracted low amounts but these have been used to confirm gender and parentage
so not useless. It simply limits the amount we can do with the samples genetically. 
 
3. I didn't see any evidence confirming maternity of the fetal samples which would
indicate if they had been collected correctly.
 
Thank you for your comment. We can only do this by looking at those genotypes that are
homozygous in the mother and the child, as we have no paternal information. On this basis, across
the 6 autosomal SNPs there were 204 genotype calls we could compare. 201 showed Mendelian
consistency. 3 genotype calls were inconsistent (presumably these were then 3 mic-calls). Added
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 the 6 autosomal SNPs there were 204 genotype calls we could compare. 201 showed Mendelian
consistency. 3 genotype calls were inconsistent (presumably these were then 3 mic-calls). Added
to the sex-chromosome data where all samples were correctly allocated gender we think we have
shown accuracy of sample collection and genotyping.
4. This is a proof of principle study which suggests this is not a good method of obtaining
genetic material. On this basis I think the article should be much shorter.
Thank you for your comment. We have shown that postal recruitment was low and DNA yields
were variable (particularly from babies) so future study designs need to take into consideration the
yield required when planning how to analyse the DNA provided. One of our study’s aims was to
assess the concordance between self-recalled pregnancy details and prospective trial data and
the authors felt it necessary and interesting to discuss the discrepancies which were uncovered,
highlighting the difficulties encountered when using postal questionnaires, and suggesting that this
is not a reliable method to phenotype preterm birth. 
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